Detalles de la búsqueda
1.
Comparison of different treatment approaches of pediatric chronic non-bacterial osteomyelitis.
Rheumatol Int
; 39(1): 89-96, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30171342
2.
Reasons for inactive disease and flare in systemic onset juvenile idiopathic arthritis patients during tocilizumab treatment.
Clin Exp Rheumatol
; 36(2): 335-341, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29303703
3.
Methotrexate treatment may prevent uveitis onset in patients with juvenile idiopathic arthritis: experiences and subgroup analysis in a cohort with frequent methotrexate use.
Clin Exp Rheumatol
; 34(4): 714-8, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27385618
4.
Systemic juvenile idiopathic arthritis-associated lung disease: A retrospective cohort study.
World J Clin Pediatr
; 13(1): 88912, 2024 Mar 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38596441
5.
Using HScore for Evaluation of Hemophagocytosis in Multisystem Inflammatory Syndrome Associated with COVID-19 in Children.
Biomedicines
; 12(2)2024 Jan 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-38397896
6.
Evaluation of etanercept (a tumor necrosis factor alpha inhibitor) as an effective treatment for joint disease in mucopolysaccharidosis type I. A case report with whole-body magnetic resonance imaging.
Front Med (Lausanne)
; 10: 1252704, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38314027
7.
Determination of Risk Factors for Severe Life-Threatening Course of Multisystem Inflammatory Syndrome Associated with COVID-19 in Children.
Children (Basel)
; 10(8)2023 Aug 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37628366
8.
COVID-19 Associated Vasculitis Confirmed by the Tissues RT-PCR: A Case Series Report.
Biomedicines
; 11(3)2023 Mar 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-36979849
9.
Standard and increased canakinumab dosing to quiet macrophage activation syndrome in children with systemic juvenile idiopathic arthritis.
Front Pediatr
; 10: 894846, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35967555
10.
Uveitis Is a Risk Factor for Juvenile Idiopathic Arthritis' Significant Flare in Patients Treated With Biologics.
Front Pediatr
; 10: 849940, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35783325
11.
The Safety and Efficacy of Tofacitinib in 24 Cases of Pediatric Rheumatic Diseases: Single Centre Experience.
Front Pediatr
; 10: 820586, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35211430
12.
Heart Involvement in Multisystem Inflammatory Syndrome, Associated With COVID-19 in Children: The Retrospective Multicenter Cohort Data.
Front Pediatr
; 10: 829420, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35311051
13.
Distinguishing Between Multisystem Inflammatory Syndrome, Associated With COVID-19 in Children and the Kawasaki Disease: Development of Preliminary Criteria Based on the Data of the Retrospective Multicenter Cohort Study.
Front Pediatr
; 9: 787353, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34858909
14.
Identification of the best cutoff points and clinical signs specific for early recognition of macrophage activation syndrome in active systemic juvenile idiopathic arthritis.
Semin Arthritis Rheum
; 44(4): 417-22, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25300700
15.
Successful treatment with tocilizumab every 4 weeks of a low disease activity group who achieve a drug-free remission in patients with systemic-onset juvenile idiopathic arthritis.
Pediatr Rheumatol Online J
; 13: 4, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25685108
Resultados
1 -
15
de 15
1
Próxima >
>>